Last $232.74 USD
Change Today +0.34 / 0.15%
Volume 2.6M
As of 8:04 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David E. I. Pyott

Chairman and Chief Executive Officer, Allergan Inc.
AgeTotal Calculated CompensationThis person is connected to 129 board members in 5 different organizations across 7 different industries.

See Board Relationships
60$17,785,957
As of Fiscal Year 2014

Background*

Mr. David E. I. Pyott has been the Chairman and Chief Executive Officer of Allergan Inc. since April 2001 and January 1998 respectively. Mr. Pyott serves as the President of the Pan-American Ophthalmological Foundation. He served as the President of Allergan Inc. from January 1998 to February 1, 2006 and again from March 27, 2011 to June 2013 and as Chief Administrative Officer since August 1, 2010. He refocused Allergan's strategy on specialty pharmaceuticals as well ...

Read Full Background

Corporate Headquarters*

2525 Dupont Drive
Irvine, California 92612

United States

Phone: 714-246-4500
Fax: 714-246-6987

Board Members Memberships*

Former Director
Director and Member of Investment & Finance Committee
Director At Large
1998-Present
Chairman and Chief Executive Officer
1999-Present
Lead Independent Director, Chairman of Compensation & Executive Personnel Committee and Member of Governance & Social Responsibility Committee
2000-2014
Former Independent Director and Member of Audit & Public Policy Committee
2001-2003
Former Director
2013-Present
Director

Education*

MA
University of Edinburgh in Scotland
MBA
London Business School

Other Affiliations*

Annual Compensation*

Salary$1,401,269
Total Annual Compensation$1,401,269

Stock Options*

All Other Compensation$52,136
Exercised Options252,000
Exercised Options Value$21,915,760
Exercisable Options2,265,200
Exercisable Options Value$343,106,749
Unexercisable Options734,756
Unexercisable Options Value$79,105,693
Total Value of Options$444,128,201
Total Number of Options3,251,956

Total Compensation*

Total Annual Cash Compensation$3,674,205
Total Short Term Compensation$1,401,269
Other Long Term Compensation$52,136
Total Calculated Compensation$17,785,957
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGN:US $232.74 USD +0.34

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
$1.1M
Michael F. Mahoney Chief Executive Officer, President and Director
Boston Scientific Corporation
$900.0K
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥170.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLERGAN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.